@article{9f12f57672f9412fb314f3e8ab7b1328,
title = "Antibiotic treatment in cystic fibrosis: Part 2: Dose optimization",
keywords = "aminoglycoside antibiotic agent, aztreonam, beta lactam antibiotic, ceftazidime, quinoline derived antiinfective agent, tobramycin, area under the curve, convulsion, cystic fibrosis, drug efficacy, drug half life, drug induced disease, drug mechanism, drug metabolism, human, lung infection, minimum inhibitory concentration, nephrotoxicity, ototoxicity, Pseudomonas aeruginosa, review",
author = "Mouton, \{Johan W.\} and Touw, \{Dani{\"e}l J.\} and Vinks, \{Alexander A.T.M.M.\} and Horrevorts, \{Alphons M.\} and Heijerman, \{Harry G.M.\}",
year = "2000",
month = may,
doi = "10.1016/S1069-417X(00)89005-6",
language = "English",
volume = "18",
pages = "33--37",
journal = "Antimicrobics and Infectious Diseases Newsletter",
issn = "1069-417X",
number = "5",
}